|
Sign In to gain access to subscriptions and/or personal tools.
|
Immunohistochemical and Ultrastructural Studies of 2,6-Dimethylaniline-induced Nasal Proliferative Lesions in a Rat Two-stage Nasal Carcinogenesis Model Initiated with N-bis(2-hydroxypropyl)nitrosamine
Takatoshi Koujitani
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Kazuo Yasuhara
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Kaoru Toyosawa
Department of Developmental Research Laboratories, Dainippon Pharmaceutical Co, Ltd, 33-94 Enoki-cho, Suita-shi, Osaka 564-0053, Japan
Akinori Shimada
Department of Veterinary Pathology, Tottori University, 4-101 Koyama-cho minami, Tottori-shi, Tottori 680-0945, Japan
Hiroshi Onodera
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Hisayoshi Takagi
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Toru Tamura
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Masao Hirose
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Kunitoshi Mitsumori
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan, mitsumor{at}cc.tuat.ac.jp, Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan
Proliferative lesions induced by 2,6-dimethylaniline (DMA) in a two-stage rat nasal carcinogenesis model were immunohistochemically and ultrastructurally investigated. Male F344 rats received diet containing 3,000 ppm DMA for 52 weeks after initiation with a single subcutaneous injection of 2400 mg/kg of N-bis(2-hydroxypropyl)nitrosamine (DHPN). Histopathologically, proliferation of Bowman's glands, glandular hyperplasias, dysplastic foci, adenomas, and carcinomas were observed in treated rats. These nasal lesions mostly arose in the olfactory mucosa of the nasal cavity. Immunohistochemically, they were positive for cytokeratin and/or collagen type IV antibodies. Ultrastructurally, intracytoplasmic dense secretory granules (200—850 nm in diameter), identical to those in normal Bowman's glands, were observed in all the lesions, providing further support from an origin from these glands. Based on their cellular characterization, growth pattern and/or proliferative activity, two morphological continua were evident, one from dysplastic foci to carcinomas and the other from proliferation of Bowman's glands to glandular hyperplasias and adenomas. These results suggest that dysplastic foci arise from Bowman's glands and progress to carcinomas, while proliferation of Bowman's glands result in glandular hyperplasias and adenomas.
Key Words: Bowman's gland carcinogenicity 2,6-dimethylaniline N-bis(2-hydroxypropyl)nitrosamine nasal cavity proliferative lesions rat
References
- Boorman GA, Morgan KT, Uriah LC (1990). Nose, larynx, and trachea. In: Pathology of the Fischer Rat, Boorman GA, Eustis SL, Elwell MR, Montgomery Jr CA, MacKenzie WF (eds). Academic Press, San Diego, CA, pp 315—337.
- Brandt I., Brittebo EB, Feil VJ, Bakke JE (1990). Irreversible binding and toxicity of the herbicide dichlobenil (2,6-dichlorobenzonitrile) in the olfactory mucosa of mice. Toxicol Appl Pharmacol 103: 491—501.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brittebo EB, Castonguay A., Furuya K., Hecht SS (1983). Metabolism of tobacco-speci fic nitrosamines by cultured rat nasal mucosa. Cancer Res 43: 4343—4348.[Abstract/Free Full Text]
- Brittebo EB, Eriksson C., Feil V., Bakke J., Brandt I. (1991). Toxicity of 2,6-dichlorothiobenzamide (chlorthiamid) and 2,6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundam Appl Toxicol 17: 92—102.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brittebo EB, Löfberg B., Tjälve H. (1981). Sites of metabolism of N-nitrosodiethylamine in mice. Chem Biol Interact 34: 209—221.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brittebo EB, Tjälve H. (1981). Formation of tissue-bound N'-nitrosonornicotine metabolites by the target-tissues of Sprague—Dawley and Fisher rats. Carcinogenesis 11: 959—963.
- Brown HR (1990). Neoplastic and potentially preneoplastic changes in the upper respiratory tract of rats and mice. Environ Health Perspect 85: 291— 304.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brown HR, Monticello TM, Maronpot RR, Randal HW, Hotchkiss JR, Morgan T. (1991). Proliferative and neoplastic lesions in the rodent nasal cavity. Toxicol Pathol 19: 358—372.[Web of Science][Medline]
[Order article via Infotrieve]
- Castonguay A., Tjälve H., Hecht SS (1983). Tissue distribution of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its metabolites in F344 rats. Cancer Res 43: 630—638.[Abstract/Free Full Text]
- Cuschieri A., BannisterLH (1973). Somehistochemical observations on the mucosubstance s of the nasal glands of the mouse. Histochem J 6: 543—558.[CrossRef][Web of Science]
- Deamer NJ, Genter MB (1995). Olfactory toxicity of diethyldithiocarbamate (DDTC) and disulfiram and the protective effect of DDTC against the olfactory toxicity of dichlobenil. Chem Biol Interact 95: 215—226.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Florin I., Ritberg L., Curvall M., Enzell C. (1980). Screening of tobacco smoke constituents for mutagenicity using the Ames' test. Toxicology 18: 219—232.
- Galloway SM, Armstrong MJ, Reuben C., Colman S., Brown B., Cannon C., Bloom AD, Nakamura F., Ahmed N., Duk S., Rimpo J., Margolin BH, Resnick MA, Anderson B., Zeiger E. (1987). Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ Mol Mutagen 10: 1—175.[Medline]
[Order article via Infotrieve]
- Harkema JR, Morgan KT (1996). Normal morphology of the nasal passages in laboratory rodents. In: Monographs on Pathology of Laboratory Animals, Respiratory System, 2nd ed, Jones TC, Dungworth DL, Mohr U (eds). Springer-Verlag, Berlin, pp 3—17.
- Haseman JK, Hailey JR (1997). An update of the National Toxicology Program database on nasal carcinogens. Mutat Res 380: 3—11.[Web of Science][Medline]
[Order article via Infotrieve]
- Hong JY, Smith T., Lee MJ, Ma BL, Ning SM, Brady JF, Thomas PE, Yang CS ( 1991). Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallysulfide. Cancer Res 51: 1509—1514.[Abstract/Free Full Text]
- Jayyosi Z., Muc M., Knoble D., Pino M., Mirsky M., Toutain H., Cassidy K., Geigar L., Kelly M. (1998). Mechanism of species specific nasal toxicity of the phosphodiesteras e IV inhibitor RP 73401 in rat. Toxicol Sci 42(S-1): 242—243 (abstract).
- Koujitani T., Yasuhara K., Ikeda T., Imazawa T., Tamura T., Toyosawa K., Shimada A., Hirose M., Mitsumori K. (2000). Sequential observation of 2,6-dimethylaniline-induced nasal lesions in a rat two-stage nasal carcinogenesis model (model) after initiation with N-bis(2-hydroxypropyl)nitrosamine. J Vet Med Sci 62: 751—756.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Koujitani T., Yasuhara K., Kobayashi H., Shimada A., Onodera H., Takagi H., Hirose M., Mitsumori K. (1999). Tumor-promoting activity of 2,6-dimethylaniline in a two-stage nasal carcinogenesi s model in N-bis(2-hydroxypropyl)nitrosamine-treated rats. Cancer Lett 142: 161—171.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Koujitani T., Yasuhara K., Kobayashi H., Shimada A., Onodera H., Takagi H., Tamura T., Hirose M., Mitsumori K. (1999). Absence of tumor promoting activity of Xylazine in a two-stage nasal carcinogenesi s model in N-bis(2-hydroxypropyl)nitrosamine-treated rats. J Toxicol Pathol 12: 203—208.[CrossRef]
- Löfberg B., Brittebo EB, Tjälve H. (1982). Localization and binding of N'- nitrosonornicotine metabolites in the nasal region and in some other tissues of Sprague—Dawley rats. Cancer Res 42: 2877—2883.[Abstract/Free Full Text]
- Mitchell D., Ibrahim S., Gusterson BA (1985). Improved immunohistochemical localization of tissue antigens using modified methacarn fixation. J Histochem Cytochem 35: 491—495.
- Morgan KT (1994). Nasal dosimetry, lesion distribution, and thetoxicologic pathologist: A brief review. Inhal Toxicol 6: 41—57.[Web of Science]
- Morgan KT, Harkema JR (1996). Nasal neoplasia. In: Monographs on Pathology of Laboratory Animals, Respiratory System, 2nd ed, Jones TC, Dungworth DL, Mohr U (eds). Springer-Verlag, Berlin, pp 87—104.
- Nagano K., Enomoto M., Yamanouchi K., Aiso S., Katagiri T. (1988). Toxicologic pathology of upper respiratory tract. J Toxicol Pathol 1: 115— 127.
- National Toxicology Program (NTP) (1990). Toxicology and carcinogenesis studies of 2,6-xylidine (2,6-dimethylaniline) in Charles River CD rats (feed studies). NTP Technical Report No. 278. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD.
- Reed CJ (1993). Drug metabolism in the nasal cavity: relevance to toxicology. Drug Metab Rev 25: 173—205.[Web of Science][Medline]
[Order article via Infotrieve]
- Rudd CJ, Mitchell AD, Spalding J. (1983). L5178Y mouse lymphoma cell mutagenesis assay of coded chemicals incorporating analyses of the colony size distributions. Environ Mutagen 5: 419.
- Sculler HM (1997). Nasal cavity carcinogenesi s by N-nitrosamines: A critical appraisal. Mutat Res 380: 13—18.[Web of Science][Medline]
[Order article via Infotrieve]
- Short CR, Joseph M. (1989). Covalent binding of [14 C]-2,6-dimethylaniline to DNA of rat liver and ethmoid turbinate. J Toxicol Environ Health 27: 85—94.[Web of Science][Medline]
[Order article via Infotrieve]
- Tjälve H., Castonguay A., Rivenson A. (1985). Microautoradiographic localization of bound metabolites in the nasal cavities of F344 rats treated with the tobacco-speci fic carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)1-butanone. J Natl Cancer Inst 74: 185—189.[Web of Science][Medline]
[Order article via Infotrieve]
- Uraih LC, Maronpot RR (1990). Normal histology of the nasal cavity and application of special techniques. Environ Health Perspect 85: 187—208.[Web of Science][Medline]
[Order article via Infotrieve]
- World Health Organization ( 1996). Toxicological evaluation of certain veterinary drug residues in food. WHO Food Additives Series: 38. World Health Organization, Geneva.
- World Health Organization ( 1998). Evaluation of certain veterinary drug residues in food. WHO Technical Report Series: 876. World Health Organization, Geneva.
- Zimmer D., Mazurek J., Petzold G., Bhuyan BK (1980). Bacterial mutagenicity and mammalian cell damage by several substituted anilines. Mutat Res 77:317—326.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 29, No. 3,
300-307 (2001)
DOI: 10.1080/019262301316905255

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|